东方阿尔法医疗健康混合发起C(014842)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
49,572,824.67 |
-17,635,367.22 |
-18,540,383.87 |
-19,990,627.94 |
| 利息合计 |
9,448.37 |
27,694.54 |
20,866.47 |
92,766.75 |
| 其中：存款利息收入 |
9,448.37 |
27,694.54 |
20,866.47 |
32,633.69 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
60,133.06 |
| 投资收益合计 |
22,155,563.56 |
-18,639,035.08 |
-14,707,345.96 |
-27,912,569.68 |
| 其中：股票投资收益 |
21,823,911.64 |
-19,873,693.35 |
-15,608,860.04 |
-30,462,880.95 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
49,253.65 |
172,655.06 |
110,471.58 |
191,031.97 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
282,398.27 |
1,062,003.21 |
791,042.50 |
2,359,279.30 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
26,924,853.11 |
929,414.16 |
-3,871,326.50 |
7,247,345.02 |
| 其他收入 |
482,959.63 |
46,559.16 |
17,422.12 |
581,829.97 |
| 费用 |
1,454,145.54 |
2,298,405.80 |
1,298,803.43 |
3,786,603.25 |
| 管理人报酬 |
1,025,640.91 |
1,653,950.15 |
927,688.99 |
2,878,845.74 |
| 基金托管费 |
170,940.16 |
275,658.37 |
154,614.86 |
479,807.62 |
| 销售服务费 |
176,036.70 |
209,476.21 |
131,178.33 |
253,651.82 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
145.88 |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
145.88 |
- |
- |
- |
| 其他费用 |
81,381.89 |
159,320.71 |
85,320.89 |
174,297.73 |
| 利润总额 |
48,118,679.13 |
-19,933,773.02 |
-19,839,187.30 |
-23,777,231.19 |
微信公众号
证券之星APP
基本资料
